The seasonal influenza vaccine is an important public health tool but is only effective in a subset of 24
Introduction 43
Influenza is a major public health burden, particularly in high-risk populations such as older adults. The 44 seasonal inactivated influenza vaccination (IIV) is estimated to be 50-70% effective in randomized 45 controlled trials of young adults (1) (2) (3) (4) (5) , and efficacy is reduced to under 50% in adults over age 65 (6) . 46 Understanding the dynamics of vaccination-induced immune responses, and the factors associated with 47 immunological protection should provide insights important for improving vaccine design. 48 49
Systems vaccinology approaches utilizing high-throughput immune profiling techniques have identified 50 signatures of response to influenza vaccination (7-14). These include pre-vaccination transcriptional 51 signatures of apoptosis-related gene modules (9), as well as B cell signaling and inflammatory modules 52
(15). Post-vaccination transcriptional signatures have also been identified, including an early interferon 53 response 1 day post-vaccination and a plasma cell response 3 and 7 days post-vaccination (13). Interferon 54 stimulated genes were upregulated in both monocytes and neutrophils between 15 and 48 hours post-55 vaccination and correlated with influenza-specific antibody responses (7, 12) . In addition, the expression 56 of genes enriched for proliferation and immunoglobulin production 7 days post-vaccination accurately 57 predicted antibody response in an independent cohort (10). Studies of the influence of aging revealed that 58
an early interferon response 1-2 days post-vaccination as well as an oxidative phosphorylation and plasma 59 cell response 7 days post-vaccination were correlated with antibody response in young adults but were 60 diminished or dysregulated in older adults (13, 14) . 61 62
Notably, previous studies of influenza vaccine response studying the effects of aging used data from a 63 single vaccine season (9) or from two consecutive seasons in which vaccine composition was identical 64
(13, 14); consequently, the generalizability of these signatures is unknown. To date, no comprehensive 65 characterization of vaccine response in both young and older adults has been reported to multiple 66 influenza vaccines which vary in composition. To address this gap, we profiled young and older adults 67 over five consecutive vaccination seasons (2010-11, 2011-12, 2012-13, 2013-14, and 2014-15) hereafter 68 referred to by the first year of each season. We developed a new automated metric to quantify antibody 69 response while accounting for baseline titers and used this novel metric to identify predictive 70 transcriptional signatures of vaccine response using post-vaccination as well as baseline gene expression 71
profiles. 72 73 74
Materials and Methods

76
Clinical Study Design and Specimen Collection 77
A total of 317 subjects were recruited at Yale University over the five vaccination seasons between 2010 78
and 2014 and HAI titers pre-(D0) and post-vaccination (D28) were available from the 294 subjects 79
reported in Table 1 . Informed consent was obtained for all subjects under a protocol approved by the 80
Human Subjects Research Protection Program of the Yale School of Medicine. Participants with an acute 81 illness two weeks prior to recruitment were excluded from the study, as were individuals with primary or 82 acquired immune-deficiency, use of immunomodulating medications including steroids or chemotherapy, 83 a history of malignancy other than localized skin or prostate cancer, or a history of cirrhosis or renal 84 failure requiring hemodialysis. Blood samples were collected into Vacutainer sodium heparin tubes and 85 serum tubes (Becton Dickinson) at four different time points, immediately prior to administration of 86 vaccine (D0) and on D2 (2011, 2012, 2013, 2014) or D4 (2010), D7, and D28 post-vaccination. 87 88
In order to understand the transcriptional program underlying a successful vaccination response, we 89
identified a subset of 134 subjects with extreme (strong or weak) antibody responses to perform 90 transcriptional profiling by microarrays. In the first three seasons, the selection criteria were a four-fold 91 increase to at least 2 strains (strong response) or no four-fold increase to any strain (weak response) as 92 described previously (14). In the fourth and fifth seasons, the adjMFC metric was used in addition to the 93 fold change criteria to account for baseline titers (11). The maxRBA response endpoint was developed 94
after the study completed, however, less than 10% (12/134) of subjects chosen for transcriptional 95 profiling had indeterminate responses by maxRBA (neither high or low responders using a 40% cutoff) 96
( Table 1) . These 12 subjects were excluded from the predictive modeling of antibody response. 97 98
HAI and VNA Analyses, Cell Sorting, RNA processing and Gene Expression Analyses 99
Detailed methods are provided in SI Appendix. 100 101 
152
We also examined the dynamics of viral titers over the course of the five seasons (SI Appendix, Fig. S3D ).
153
The A/California 7/2009 H1N1 strain was introduced into the seasonal vaccine in 2010 and remained 154 through the 2014 season; however, pre-vaccine titers to this strain were consistently lower in older vs. 155
young adults for 2011-2014. While we did not follow the same subjects across multiple seasons, 50-80% 156 of young and 80-98% of older adults self-reported receiving influenza vaccine in the previous year. Taken 157 together, these results support existing evidence that the capability for antibody persistence is reduced 158 with age (16). 159
Figure 1
Influenza-Specific Antibody Titers. (A) An illustration of the maximum Residual after Baseline Adjustment (maxRBA) method for hemagglutination inhibition (HAI) titers to the B/Wisconsin/1/2010 strain in the 2012 season. An exponential curve (blue) is fit to the data and the residual is used to stratify subjects into high and low responders. Subjects with largest positive residuals are high responders (green) and subjects with smallest negative residuals are low responders (red). maxRBA is calculated using the maximum residual across all vaccine strains. (B and C) Violin plots of pre-vaccination HAI titers (B) and HAI responses measured by maxRBA (C) are separated by season and gender to compare age groups. Crossbars indicate the mean. Not Significant (ns) p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 independent two-sided Wilcoxon rank sum test. To identify correlates and predictors of vaccine response, we selected a subset of individuals (20 -40 22 subjects per season) from young and older adult cohorts who had strong or weak antibody responses 23 according to HAI titers and performed longitudinal transcriptional profiling pre-vaccination (baseline) 24
and 4 (2010 cohort) or 2 days (all other cohorts), 7 days, and 28 days post-vaccination (Table 1 ; 25
Methods). We first performed differential expression analysis independently in each season without 26
differentiating subjects by antibody response. We compared each post-vaccination time point to baseline 27
and found a vaccine-induced signature that comprised a total of 2,462 significantly differentially 28 expressed genes (DEGs) over all five seasons (FDR < 0.05, Fold Change > 1.25; SI File 1). 29 30
Most of the DEGs were from the first two seasons whereas vaccination in the latter three seasons induced 31
relatively weak changes ( Fig. 2A ; SI Appendix, Fig. S4E ). In fact, a substantial fraction of DEGs were 32
unique to a single season and not differentially expressed at any time point in another season (Young: 33 38%, Older: 75%). In young adults, there were 1,330 DEGs shared across two or more seasons while in 34 older adults there were 265 shared DEGs. In both young and older adults, a substantial fraction of these 35
shared genes was differentially expressed 28 days post-vaccination (SI Appendix, Fig. S4F ). To assess 36
whether vaccine-induced changes were consistent between seasons, we divided the 2,462 DEGs into 7 37 clusters by hierarchical clustering ( Fig. 2A ; SI File 2) and tested for their activity in every season using 38
QuSAGE (17) (SI Appendix, Fig. S5 ). In young adults, three of the clusters (B, F, G) had significant, but 39
opposite, activity during the 2010 and 2011 seasons, while these clusters were relatively consistent across 40 seasons in older adults. Genes in cluster A were induced strongly in the 2011 season in both age groups 41 and notably enriched for multiple pathways related to mitochondria, including mitochondrial inner 42 membrane, oxidative phosphorylation, respiratory electron transport, citric acid (TCA) cycle and 43 respiratory electron transport, and mitochondrial respiratory chain complex assembly (FDR < 0.05; SI 44
File 2). These findings reflect our previous identification of a mitochondrial biogenesis signature 45 associated with influenza vaccine antibody response (14). Cluster D was only significantly induced in the 46 2013 season at 7 and 28 days post-vaccination and was not significantly enriched for any gene sets tested 47
(FDR > 0.05; SI File 2). The cluster with the most consistent expression pattern across the five seasons 48 was cluster C, which was enriched for pathways related to Toll-like receptor signaling, B and T cell 49 signaling, NF-kB signaling, MAPK signaling, cell senescence or proliferation, and apoptosis (SI File 2). 50
Interestingly, cluster C contains three genes (DUSP1, DUSP2, CCL3L3) which were significantly 51 downregulated 28 days post-vaccination in four of five seasons. CCL3L3 is a ligand for CCR1, CCR3 and 52
CCR5, known to be chemotactic for monocytes and lymphocytes (18). DUSP1 and DUSP2 are dual 53 specificity phosphatases; DUSP2 dephosphorylates STAT3, leading to inhibition of survival and 54
proliferation signals (19-21), and an age-associated decrease in DUSP1 function contributed to 55 inappropriate IL-10 production in monocytes before and after influenza vaccination (22). To determine 56 whether downregulation of these three genes was a result of changes in cell subset composition or 57 observed in subpopulations of cells, we performed transcriptional profiling on sorted B and T cells in a 58 subset of individuals from three seasons. DUSP1 and DUSP2, but not CCL3L3, were significantly 59 downregulated 28 days post-vaccination over multiple seasons in CD4 and CD8 T cells of young adults 60
(One sided t-test p < 0.01; Fig. 2C , SI Appendix, Fig. S4C-D) . Furthermore, while DUSP2 was only 61 significantly decreased in PBMCs of older individuals in the 2011 season, expression of DUSP2 was 62 significantly decreased 28 days post-vaccination in sorted CD4 and CD8 T cells from older individuals in 63 multiple seasons (Fig. 2C) . Thus, the downregulation of DUSP2 28 days post-vaccination is observed in 64 the T cell compartment of both young and older adults. 65 66
To further assess shared patterns in vaccine-induced changes across five seasons, we performed a Given the substantial seasonal variation in the number of DEGs, we next performed an analysis of 87 differential expression of gene modules using QuSAGE to quantify the gene module activity of 346 88 previously defined BTMs (23). There were 262 differentially expressed modules (DEMs) (FDR < 0.05; SI 89
File 4, SI Appendix, Fig. S4A Shared Vaccine-Induced Signatures Across Five Seasons 106 107
The differential expression approach is limited by fixed fold change and significance cutoffs that may 108 vary between seasons. To increase our power to identify shared signatures across seasons and in older 109
adults, we performed a meta-analysis at the individual gene and gene module level. We identified 338 110
genes with significantly altered expression post-vaccination (FDR < 0.05; SI File 5). In young adults, we 111
identified significant genes at D2, D7 and D28 with little overlap among genes on each day. Genes 112 induced on D2 were moderately enriched for innate immune genes from InnateDB (http://innatedb.com/) 113
including MYH9, TYK2, GLRX, and IP6K1 (p = 0.12, hypergeometric test). Some of the genes 114 consistently induced at D7 included IGLL1, CD38, ITM2C, TNFRSF17, MZB1, and TXNDC5. We 115 previously identified TNFRSF17, B cell maturation antigen, as induced seven days following influenza 116 vaccination (26), and it was also identified as a predictive marker gene of antibody response to multiple 117 vaccines including influenza, meningococcal conjugate (MCV4), and yellow fever (YF17D) vaccines (11, 118
23, 27-29). Consistent with the individual season analysis, the majority of genes identified by the meta-119
analysis were altered at D28; these D28 DEGs included DUSP1, DUSP2, and CCL3L3, identified in the 120 single-season analysis, and many other downregulated genes including IL1B, CCL3, and JAK1. Thus, 121
there are consistent changes identified across all seasons in young adults at every time point measured. 122 123
In older adults, we identified 125 genes with significantly altered expression at D28, but no genes with 124 significantly altered expression at D2 or D7 (SI File 5). The most significantly increased gene at D28 is 125 XRN1, the primary 5' to 3' cytoplasmic exonuclease involved in mRNA degradation (30). XRN1 plays a 126 critical role in the control of RNA stability in general, but in addition appears to regulate the response to 127 viral infection at several levels-for example, by targeting viral RNAs for degradation (31), or regulating 128 levels of potential activating ligands such as double-stranded RNA (32). Notably, XRN1 has also been 129
reported to facilitate replication of influenza and other viruses by inhibiting host gene expression (33, 34) 130 -suggesting that dysregulated expression of XRN1 in older adults could influence host response to 131 vaccination. We identified 3 genes shared between both age groups: ARRDC3 and USP30 were 132 downregulated while TNPO1 was upregulated, all at D28. ARRDC3 encodes a member of the arrestin 133 protein family which regulates G protein-mediated signaling and is implicated in regulating metabolism 134
(35). USP30 is a ubiquitin-specific protease that acts as a mitochondrial deubiquitinating enzyme (36).
135
TNPO1 encodes Transportin-1 that serves to import proteins into the nucleus (37). The effect sizes of all 136 genes at D28 were positively correlated between young and older adults with weak positive associations 137 at D2 and D7 (Fig. 3) . These results provide additional evidence that transcriptional changes are broadly 138 similar in young and older adults at D28 post-vaccine. 139 140
We carried out a gene set level meta-analysis using QuSAGE to combine probability density estimates of 141 gene module activity for each season (38). We identified 186 BTMs significantly altered post-vaccination 142 across five seasons (FDR < 0.05; SI File 4). The module with the largest increase in activity was plasma 143 cells, immunoglobulins (M156.1) which peaked on D7 with a combined fold change of 1.17 in young 144
adults and 1.08 in older adults at D7. Most BTMs showing significant changes were identified in young 145
adults and, unlike the individual gene level, there was a large overlap between sets at each time point, 146
suggesting the same module changes were sustained over the 28 days following vaccination (SI Appendix, 147 Fig. S4A ). Indeed, a heatmap of module activity shows that in young adults, transcriptional changes 148
continued to intensify at D28 for many modules rather than returning to the baseline state (SI Appendix, 149 Fig. S6 ). Older adults showed a qualitatively similar pattern to young adults on D2 and D28, but not D7. 150
The majority (40/59) of the modules significantly altered in older adults on D28 were also significantly 151 altered in young adults at D28 (SI Appendix, Fig. S4A ). The modules downregulated on D28 in both 152 young and older adults were annotated with antigen processing and presentation (M95.0, M95. A meta-analysis across all five seasons revealed markedly different baseline transcriptional profiles in 162 young vs. older adults, with 1,072 genes significantly altered (FDR < 0.05, SI File 6). Of these age-163 associated genes, 204 genes were also significantly induced by the vaccine in young adults and 125 genes 164
in older adults. We tested whether age-associated genes were enriched for vaccine-induced genes at each 165 time point and found that the overlap was significantly more than expected by chance for the 6 age-166 associated genes induced on D7 in young adults (p = 0.017, hypergeometric test). Of these 6 overlapping 167 genes, 5 genes (ITM2C, MZB1, IGLL1, TNFRSF17, and TXNDC5) exhibited decreased basal expression 168 in older adults while 1 (SELENOS) exhibited increased basal expression compared to young adults. While 169 these genes were induced in young adults, they were not significantly induced in older adults on D7. 170
Notably, MZB1 and TNFRSF17 are B cell associated genes, suggesting that older adults have decreased B 171 cell activity pre-vaccination and fail to induce the same B cell response as young adults at D7. SELENOS 172 encodes selenoprotein S, which is involved in degrading misfolded endoplasmic reticulum (ER) proteins 173 and influences inflammation via the ER stress response (39, 40) . Our results show that age-associated 174
genes are significantly over-represented in the set of genes altered in young adults 7 days post-175
vaccination. 176 177
We next performed a meta-analysis of BTMs between age groups at baseline and identified 120 modules 178 significantly altered with age (FDR < 0.05, SI File 7). Most of the modules that were decreased with age 179
were associated with adaptive immunity, whereas those that had increased expression with age were 180 mostly innate and inflammatory modules (reflecting age-associated inflammatory dysregulation; SI 181 Appendix, Fig. S7B ). Of these 120 modules, 52 were also significantly altered post-vaccination; however, 182 the overlap at each time point was not significantly more than expected by chance (hypergeometric p > 183 0.05, SI Appendix, Fig. S7A ). Thus, age-related genes are enriched among the genes induced at D7 in 184 young adults while no gene modules were significantly over-represented. 185 186
Post-Vaccination Predictors of Antibody Response 187 188
We next asked whether any transcriptional changes post-vaccination could discriminate high antibody 189
responders (HR) from low antibody responders (LR sets from independent groups were used to validate the models. For the models built from expression 198 changes at D2 or D28, no studies at identical time-points were available, so we attempted to validate these 199 models on studies with similar time points (day 1 or 3 in (11) and day 14 in (13)). While we could build 200 predictive models on our data (median AUC ≥ 0.75) they did not validate on other data sets at the 201 (different) time points available (median AUC ≤ 0.55).
203
For D7 post-vaccine, direct validation data were available in independent datasets. In young adults, D7 204 models were predictive for HR in the discovery and validation (11) datasets (Fig. 4A ). Another MAP 205 kinase phosphatase acting on ERK1/2, DUSP5, was one of 37 genes selected by the Lasso model whose 206
expression was increased in HR ( Fig. 4C ). DUSP5 is expressed in multiple immune cell types such as B 207 cells (including plasma cells), T cells, dendritic cells, macrophages and eosinophils (41). In murine T 208
cells, DUSP5 appears to promote the development of short-lived effector CD8+ T cells and inhibit 209 memory precursor effector cell generation in an LCMV infection model (42); while optimizing memory 210 precursor cell generation would be the goal of vaccination, the upregulation of DUSP5 in HR could 211 reflect regulation of the balance between short-lived vs. memory precursor effector CD8+ T cells. A 212 sensitivity analysis of the maxRBA cutoff shows that the average expression of predictive genes is 213 consistent across a range of definitions for HR and LR (20 th -40 th percentile; SI Appendix, Fig. S2C-D) . 214
Using LogMiNeR, the models were consistently enriched for the B Cell signature as well as the KEGG 215 chemokine signaling pathway (SI File 8). 216 217
In older adults, models predicting antibody responses built from D7 gene expression were highly 218 predictive in the discovery dataset but did not validate on an independent dataset (13) (Fig. 4B, D) . 219
Expression of the Solute Carrier Family 25 gene SLC25A20 of mitochondrial transporters contribute to 220 predicting HR vs. LR in older adults. SLC25A20 is the carrier for carnitine and acylcarinitine (43), and so 221
would be expected to be crucial for the transport of fatty acids into mitochondria. The models of response 222
in older adults were significantly enriched for several BTMs of monocyte signatures as well as TLR and 223
Inflammatory Signaling (M16), which positively predicted vaccine response; together with previous 224 studies linking age-associated impairments in TLR function to influenza vaccine antibody response (44, 225 45), these findings provide additional support for the crucial role of innate immune function in 226 vaccination (SI File 8).
228
Notably, none of the models built in young adults at any time point are predictive in older adults (AUC ≤ 229 0.5). In fact, models built on transcriptional changes at D28 in young adults had a median AUC near 0.8 230 in young adults, but no more than 0.3 in older adults, suggesting that the same genes predictive of HR in 231 young adults predicted LR in older adults (SI Appendix ; Fig. S8E ). The Lasso models making these 232 predictions often chose a single gene, Killer Cell Lectin Like Receptor B1 (KLRB1, also known as 233 CD161), which was driving this inverse pattern (Fig. 4E) . KLRB1 is an inhibitory receptor on NK cells 234 (46, 47) and is also a biomarker of Th17 cells (48-50). Notably, changes in KLRB1 expression in sorted 235
CD4 and CD8 T cells at D28 closely mirrored the changes in PBMCs for young, but not older adults (SI 236
Appendix, Fig. S8A-B) . We confirmed this inverse correlation between age groups on a genome-wide 237 scale by performing a meta-analysis comparing HR vs. LR (SI File 9). We observed a weak negative 238 correlation in effect sizes between young and older adults at D28 (r = -0.27; Fig. 4F ). We confirmed this 239 negative correlation in effect sizes between young and older adults using a virus neutralization assay 240
(VNA) in a test sample of blood from seasons 2011 and 2012 (r = -0.32; SI Appendix, Fig. S8D ). Thus, 241
expression changes of many genes at D28 have opposing signs between age groups for the effect size 
Baseline Predictors of Antibody Response 261 262
We next sought to identify baseline transcriptional predictors of antibody response. In young adults, 263
LogMiNeR models were predictive above random on discovery and validation (11) (Fig. 5A) datasets. 264
Lasso models included the gene VASH1, known as an angiogenesis inhibitor and mediator of stress 265 resistance in endothelial cells, which was expressed at lower levels in HRs (Fig. 5C) ; notably, the KEGG 266 gene set leukocyte transendothelial migration was significantly enriched in over 50% of the models when 267
LogMiNeR was used with ImmuNet as prior knowledge (51). Another predictive gene, EIF4E, a 268 translation initiation factor important in type I interferon production, was decreased in HRs. A sensitivity 269
analysis of the maxRBA cutoff shows that the average expression of predictive genes is consistent across 270 a range of definitions for HR and LR (20 th -40 th percentile; SI Appendix, Fig. S2E-F) . Finally, the BTMs 271 cell adhesion (M51) and B cell surface signature (S2) were consistently enriched in the models (SI File 272 8). In older adults, LogMiNeR models were also predictive on the discovery and one validation dataset 273 (9) (Fig. 5B ) but not another (13) (SI Appendix, Fig. S8C ). Two of the individual genes that predict 274 response, ALDH1A1 and ALDH3B1, are aldehyde dehydrogenases which metabolize vitamin A to retinoic 275 acid ( Fig. 5D ). Recently, aldehyde dehydrogenases were implicated in antiviral innate immunity as To link our findings to previously identified influenza vaccine signatures, we performed a comprehensive 297 assessment of the behavior of 1,603 previously published individual gene and gene module signatures in 298 our data set. We manually curated published signatures from studies that carried out transcriptional 299
profiling on adult cohorts after influenza vaccination (9, 11, 13, 15, 27, 53). We further limited the 300 signatures to shared time points post-vaccination. This set of findings describe 935 response-associated 301
and 653 temporal signatures in B cells and PBMCs as well as 15 age-associated signatures (SI File 10). 302 303
Most of the previously published signatures we validated in our data were single genes induced 7 days 304 post-vaccination in PBMCs or B cells (SI Appendix, Fig. S9 ). Of the 135 signatures that showed 305 significant differential expression (p < 0.001), 103 changed in the same direction as the published 306 signature. In PBMCs we validated 26 D7 vaccine-induced genes including four genes independently 307 discovered in our meta-analysis: CD38, ITM2C, TNFRSF17, and SPATS2 (SI Appendix, Fig. S9B ) (11).
308
CD38 is upregulated on the surface of antibody secreting cells, and TNFRSF17, or B cell maturation 309 antigen (BCMA) is a receptor for B cell activating factor (BAFF) expressed on memory B cells and 310 plasma cells (54). Notably, validated vaccine-induced genes in B cells include several associated with 311 mitochondrial function whose expression was upregulated at Day 7, including UQCRQ (ubiquinol 312 cytochrome c reductase, complex III, subunit VII), ME2 (NAD-dependent malic enzyme), TAL 313 (transaldolase 1), and GLDC (glycine decarboxylase) (SI Appendix, Fig. S9A ). We validated several 314 modules significantly associated with antibody response at baseline in young and older adults (SI 315
Appendix, Fig. S9D ) (13). Of these modules, one positively associated with antibody response (enriched (II) (M11.0)). Interestingly, these latter three modules are also enriched in predictive models of HR vs LR 320 from D7 fold changes. Finally, there are seven validated single genes whose fold change at D7 is 321 positively associated with antibody response in young adults (SI Appendix, Fig. S9C ) (11). One of these 322 genes, HSP90B1, or gp96 -an ER-based chaperone protein implicated in innate and adaptive immune 323 function -is also selected as a predictive gene of antibody response (55, 56). 324 325
Discussion
327
This study is the first to evaluate the transcriptomic response to influenza vaccination in young and older 328 adults in five consecutive vaccine seasons with three different vaccine compositions. We sought to 329 address whether common signatures of vaccine response or transcriptional predictors of antibody 330 response could be elucidated despite differences in seasonal vaccine composition. 331
332
To adjust for the inverse relationship between baseline antibody titers and vaccine-induced antibody 333 production, we developed a novel vaccine response endpoint, maxRBA, to automatically correct for 334 variation in baseline titers; this allowed us to demonstrate an age-associated decrease in antibody response 335
in gender-matched participants. Comparing the transcriptional profiles across five seasons revealed 336 substantial seasonal variability in both the magnitude as well as direction of response. For example, the 337 vaccines administered in the 2010 and 2011 seasons elicited large changes in gene expression, but no 338 statistically significant DEGs were found in the 2014 season despite a comparable sample size. seasons are intriguing because in both seasons the composition of the vaccine was identical to that in the 345 preceding year, perhaps suggesting that these gene signatures reflect a relatively recent recall response. In 346 contrast, the 2012 and 2013 vaccines each contained two strains which had not been present in the 347 previous year's vaccine. We did not observe the same trends in older adults; nonetheless, our results 348
indicate that changes in vaccine composition, influencing factors such as vaccine strain immunogenicity 349 and the effects of previous vaccination or infection, can alter the transcriptional response to influenza 350 immunization.
352
Despite substantial inter-season variability, we identified shared vaccine-induced signatures in both young 353
and older adults at D28. We expected D28 expression profiles to be similar to baseline; however, there 354
were numerous transcriptional changes at D28 that were consistent across seasons with different vaccine 355
compositions. Some of the most significant changes identified from single-season differential expression 356 analysis in four out of five seasons were in DUSP1, DUSP2, and CCL3L3; moreover, DUSP2 expression 357 was also decreased in sorted CD4+ and CD8+ T cells from both young and older adults at D28. It is 358 notable that a basal age-related alteration in phosphorylation of DUSP1, a negative regulator of IL-10 359 production, was associated with increased expression of IL-10 in monocytes from older adults (seen pre-360
and post-influenza vaccination) (57) and that increased DUSP6 expression was associated with impaired 361
T cell receptor signaling in CD4+ T cells from older adults (58). These results emphasize the importance 362 of modulation of MAP kinase function, such as through phosphatases of the DUSP family, in the 363 regulation of influenza vaccine response. Surprisingly, early response signatures at D2 and D7 post-364 vaccination were not as consistent across seasons as D28 signatures in a meta-analysis of genes and gene 365 modules. One potential hypothesis that explains this observation is that temporal variations in early 366 responses across seasons were not captured at the time points used, and that responses at D28 are less 367 variable, and thus were captured in every season. It is possible that this common transcriptional program 368 at D28 reflects a convergence towards resolution of the vaccine response in both young and older adults. 369
However, a substantial number of BTMs showed upregulated activity at D28 without evidence of 370 resolution to baseline, particularly in young adults; notably, we previously found evidence of enhanced 371
TNF-alpha and IL-6 production in monocytes 28 days post-influenza immunization (57) that was blunted 372
in monocytes from older adults. Thus, it remains possible that the transcriptional signature we observed 373 also reflects elements of an ongoing immune activated state several weeks after vaccination.
375
We built predictive models of antibody response from post-vaccination transcriptional responses which 376
were successfully validated in an independent cohort of young adults. Although transcriptional changes 377
were correlated between age groups at D28, models of antibody response built in young adults did not 378 validate in older adults. Strikingly, we identified a genome-wide inverse correlation between the effect 379 size of genes discriminating HR and LR at D28 and confirmed this finding with both HAI and VNA 380 titers. A similar inverse correlation related to age was recently reported using baseline (D0) gene 381 expression signatures (15). We identified a single gene, KLRB1, whose expression alone predicted 382 response in both age groups but in opposite directions. In young adults, changes in KLRB1 expression 383
were also observed in sorted CD4 and CD8 T cells, perhaps reflecting the finding that KLRB1 expression 384
is increased in populations of memory T cells (59). Furthermore, KLRB1 hi CD8+ T cells are self-renewing 385 memory cells that are able to reconstitute the memory T cell pool after chemotherapy (60). Thus, KLRB1 386 induction in young adults may reflect an increase in memory T cell populations. In older adults, these 387 expression patterns were not observed in sorted T cells, implying that KLRB1 expression in another cell 388 type, perhaps NK cells or Th17 cells, was the basis for the predictive performance. 389 390
We also built and validated predictive models of antibody response in young and older adults from D0 391 gene expression data. One of the predictive genes in young adults, VASH1, showed evidence of genetic 392 regulation of gene expression in a previous study of influenza vaccination, suggesting that genotype may 393
have predictive power to explain the antibody response (8). Leukocyte migration and a B cell surface 394 signature were enriched in the predictive models. This is consistent with a recently reported meta-analysis 395 which included baseline transcriptional profiles from the 2010, 2011, and 2012 seasons of the present 396 study and validated a temporally stable B cell receptor signaling gene module that positively predicted 397 response at baseline (15). While the B cell surface signature (S2) module we identified was not the same 398
one identified in the previous study, our findings further support the implication of B cell transcriptional 399 signatures as pre-vaccine biomarkers of antibody response in young adults. In older adults, we 400 incorporated prior knowledge on gene coexpression using LogMiNeR to identify monocyte signatures 401 which were enriched in the predictive models and were negatively associated with antibody response. Our 402 model validated on one older adult cohort (9) but not another (13); this may reflect substantial variability 403 in cohorts of older adults, which would be expected to be more heterogeneous in terms of comorbid 404 medical conditions or medication use compared to young adults. Finally, we linked our findings to 405 previously identified influenza vaccination signatures by performing a comprehensive assessment of 406 1,603 previously published individual gene and gene module signatures. We present the signatures that 407 validate in any season or a meta-analysis of all seasons of our data to highlight the most consistent set of 408 genes and gene modules associated with vaccination or antibody response in PBMC and B cells. 409 410
In summary, we profiled nearly 300 young and older adults across five vaccination seasons and, despite 411 substantial seasonal variability in vaccine-induced transcriptional signatures, identified a core 412 transcriptional signature shared between seasons and across age groups 28 days post-vaccination. In 413 addition, we defined a new endpoint (maxRBA) to capture antibody response relative to baseline titer and 414
were able to predict response in young and older adults separately using baseline transcriptional profiles. 415
Our results suggest that vaccine composition, in concert with differences in pre-existing immunity and 416 other individual factors, dramatically influences immune response to inactivated influenza vaccination. 417
Furthermore, this work is a step toward understanding the underlying mechanisms of response in older 418 adults which may be beneficial for rationally designing more effective vaccines. 419 Acknowledgments 421 422
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